Stockscreener 앱 받기
11.57
0.61%
0.07
Roivant Sciences Ltd 주식(ROIV)의 최신 뉴스
Barclays PLC Purchases 75,609 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat
Mayukh Sukhatme Sells 412,584 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) Stock - MarketBeat
Roivant sciences executive sells common shares worth $4.97 million By Investing.com - Investing.com South Africa
Roivant sciences executive sells common shares worth $4.97 million - Investing.com
Geode Capital Management LLC Acquires 1,460,205 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat
Roivant Sciences Ltd. (NASDAQ:ROIV) Shares Purchased by Retirement Systems of Alabama - MarketBeat
Ramaswamy Urges BuzzFeed to Cut Jobs, Air More Conservative Voices - MSN
Trump administration will have financial ties to biotechs - BioCentury
State Street Corp Buys 1,118,561 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat
Roivant Sciences Ltd. (NASDAQ:ROIV) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
What is Leerink Partnrs' Estimate for ROIV Q3 Earnings? - MarketBeat
Several Positive Developments Lifted Roivant (ROIV) in Q3 - Insider Monkey
Edgestream Partners L.P. Buys Shares of 48,226 Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 762,953 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat
MetLife Investment Management LLC Has $2.60 Million Stock Position in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat
Roivant to stop lung disease drug development after trial failure - MSN
Roivant Sciences: A Biotech Growth Play With Major Ambitions (NASDAQ:ROIV) - Seeking Alpha
Roivant Sciences Ltd. (NASDAQ:ROIV) Holdings Cut by Melqart Asset Management UK Ltd - MarketBeat
Maven Securities LTD Purchases Shares of 400,000 Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat
Charles Schwab Investment Management Inc. Buys 646,627 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat
Roivant Phase II miss for namilumab - The Pharma Letter
Erste Asset Management GmbH Buys New Shares in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat
Roivant Sciences Ends Namilumab Study Due to Inefficacy - TipRanks
Roivant falls as lung disease drug fails in mid-stage study - XM
TOMS Capital Investment Management LP Invests $46.33 Million in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat
Thrivent Financial for Lutherans Sells 62,228 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat
Fmr LLC Increases Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat
Rubric Capital Management LP Sells 600,000 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat
Loomis Sayles & Co. L P Has $45.15 Million Stock Position in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat
Eric Venker Sells 100,000 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) Stock - MarketBeat
Roivant Sciences president Eric Venker sells $1.13 million in shares By Investing.com - Investing.com Nigeria
Roivant Sciences president Eric Venker sells $1.13 million in shares - Investing.com
Thompson Siegel & Walmsley LLC Takes $5.93 Million Position in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat
Roivant Sciences Ltd. (ROIV) Reports Q2 Loss, Misses Revenue Estimates - MSN
Roivant Sciences' (NASDAQ:ROIV) Shareholders Should Assess Earnings With Caution - Yahoo Finance
Principal Financial Group Inc. Trims Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat
Vivek Ramaswamy's Net Worth Is 9 Figures—See How the DOGE Co-Lead Made His Millions - Yahoo Finance
Andreas Halvorsen's Recent Transaction in Roivant Sciences Ltd - GuruFocus.com
Roivant Sciences Ltd. (ROIV) Quarterly 10-Q Report - Quartzy
Vivek Ramaswamy: 10 things you ought to know about Trump's DOGE co-lead - MSN
Roivant Sciences Ltd - Reuters
Roivant Sciences Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 - Marketscreener.com
Roivant Sciences Ltd. (NASDAQ:ROIV) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Trump’s appointment of Ramaswamy sparks speculation on Korean biotech firms linked to Roivant - KBR
Who is Vivek Ramaswamy? Know about his early life, education, and role as head of the new "Department of Government Efficiency" (DOGE) - MSN
From Vadakkanchery to top US Govt post: Vivek Ramaswamy's Kerala roots - Mathrubhumi English
The Analyst Landscape: 5 Takes On Roivant Sciences - Benzinga
How Vivek Ramaswamy Became A Billionaire - Forbes
Who is Vivek Ramaswamy? What to know about Cincinnati billionaire part of Trump's Cabinet - The Cincinnati Enquirer
Vivek Ramaswamy Net Worth 2024: How He Built a Billion-Dollar Empire - Black Star News
Vivek Ramaswamy's journey from bright son of immigrants to being Donald Trump's pick - The Economic Times
Roivant Sciences Ltd. (NASDAQ:ROIV) Q2 2024 Earnings Call Transcript - Insider Monkey
2.88%
2.65%
자본화:
|
볼륨(24시간):